Alkermes plc (ALKS)
USD 30.05
(-5.1%)
USD 30.05
(-5.1%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 287.73 Million USD | -0.88% |
| 2022 | 290.27 Million USD | -0.87% |
| 2021 | 292.8 Million USD | 7.6% |
| 2020 | 272.11 Million USD | -0.79% |
| 2019 | 274.29 Million USD | -0.78% |
| 2018 | 276.46 Million USD | -0.71% |
| 2017 | 278.43 Million USD | -0.79% |
| 2016 | 280.66 Million USD | -1.25% |
| 2015 | 284.2 Million USD | -19.08% |
| 2014 | 351.22 Million USD | -3.05% |
| 2013 | 362.25 Million USD | -17.92% |
| 2012 | 441.36 Million USD | -0.12% |
| 2011 | 441.88 Million USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 50.22 Million USD | -68.68% |
| 2008 | 160.32 Million USD | 2.18% |
| 2007 | 156.89 Million USD | -43.87% |
| 2006 | 279.51 Million USD | 1.1% |
| 2005 | 276.48 Million USD | 125.55% |
| 2004 | 122.58 Million USD | -26.41% |
| 2003 | 166.58 Million USD | -19.83% |
| 2002 | 207.8 Million USD | -1.9% |
| 2001 | 211.82 Million USD | -4.92% |
| 2000 | 222.79 Million USD | 684.02% |
| 1999 | 28.41 Million USD | 119.72% |
| 1998 | 12.93 Million USD | 18.5% |
| 1997 | 10.91 Million USD | 10.24% |
| 1996 | 9.9 Million USD | 17.86% |
| 1995 | 8.4 Million USD | 27.27% |
| 1994 | 6.6 Million USD | 214.29% |
| 1993 | 2.1 Million USD | 950.0% |
| 1992 | 200 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 287.09 Million USD | -0.22% |
| 2024 Q3 | 285.82 Million USD | -0.22% |
| 2024 Q2 | 286.45 Million USD | -0.22% |
| 2023 Q3 | 288.36 Million USD | -0.22% |
| 2023 Q2 | 289 Million USD | -0.22% |
| 2023 Q4 | 287.73 Million USD | -0.22% |
| 2023 Q1 | 289.63 Million USD | -0.22% |
| 2023 FY | 287.73 Million USD | -0.88% |
| 2022 Q1 | 396.18 Million USD | 35.31% |
| 2022 Q2 | 391.36 Million USD | -1.22% |
| 2022 Q3 | 386.63 Million USD | -1.21% |
| 2022 Q4 | 290.27 Million USD | -24.92% |
| 2022 FY | 290.27 Million USD | -0.87% |
| 2021 FY | 292.8 Million USD | 7.6% |
| 2021 Q3 | 293.43 Million USD | -27.68% |
| 2021 Q2 | 405.73 Million USD | -1.09% |
| 2021 Q4 | 292.8 Million USD | -0.22% |
| 2021 Q1 | 410.2 Million USD | 50.75% |
| 2020 Q2 | 372.64 Million USD | -0.56% |
| 2020 Q4 | 272.11 Million USD | -26.33% |
| 2020 FY | 272.11 Million USD | -0.79% |
| 2020 Q1 | 374.75 Million USD | 36.63% |
| 2020 Q3 | 369.38 Million USD | -0.88% |
| 2019 Q1 | 275.92 Million USD | -0.2% |
| 2019 Q4 | 274.29 Million USD | -2.56% |
| 2019 Q3 | 281.49 Million USD | -0.97% |
| 2019 Q2 | 284.24 Million USD | 3.02% |
| 2019 FY | 274.29 Million USD | -0.78% |
| 2018 Q1 | 278.08 Million USD | -0.12% |
| 2018 Q4 | 276.46 Million USD | -0.2% |
| 2018 Q3 | 277 Million USD | -0.19% |
| 2018 Q2 | 277.54 Million USD | -0.19% |
| 2018 FY | 276.46 Million USD | -0.71% |
| 2017 FY | 278.43 Million USD | -0.79% |
| 2017 Q4 | 278.43 Million USD | -0.2% |
| 2017 Q3 | 278.99 Million USD | -0.2% |
| 2017 Q2 | 279.55 Million USD | -0.2% |
| 2017 Q1 | 280.1 Million USD | -0.2% |
| 2016 FY | 280.66 Million USD | -1.25% |
| 2016 Q4 | 280.66 Million USD | -0.68% |
| 2016 Q1 | 283.66 Million USD | -0.19% |
| 2016 Q2 | 283.12 Million USD | -0.19% |
| 2016 Q3 | 282.57 Million USD | -0.19% |
| 2015 Q3 | 286.51 Million USD | -17.68% |
| 2015 Q2 | 348.05 Million USD | -0.45% |
| 2015 Q4 | 284.2 Million USD | -0.8% |
| 2015 FY | 284.2 Million USD | -19.08% |
| 2015 Q1 | 349.63 Million USD | -0.45% |
| 2014 Q3 | 352.8 Million USD | -0.45% |
| 2014 Q2 | 354.38 Million USD | -0.44% |
| 2014 Q1 | 355.96 Million USD | -0.52% |
| 2014 FY | 351.22 Million USD | -3.05% |
| 2014 Q4 | 351.22 Million USD | -0.45% |
| 2013 Q1 | 362.25 Million USD | -0.03% |
| 2013 Q4 | 357.81 Million USD | -0.36% |
| 2013 Q3 | 359.12 Million USD | -0.43% |
| 2013 Q2 | 360.69 Million USD | -0.43% |
| 2013 FY | 362.25 Million USD | -17.92% |
| 2012 FY | 441.36 Million USD | -0.12% |
| 2012 Q1 | 441.36 Million USD | -0.07% |
| 2012 Q2 | 441.08 Million USD | -0.06% |
| 2012 Q3 | 363.84 Million USD | -17.51% |
| 2012 Q4 | 362.34 Million USD | -0.41% |
| 2011 Q4 | 441.66 Million USD | -0.04% |
| 2011 FY | 441.88 Million USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | 441.85 Million USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q1 | 50.22 Million USD | -26.89% |
| 2009 Q2 | 44.05 Million USD | -12.27% |
| 2009 Q3 | 37.86 Million USD | -14.06% |
| 2009 FY | 50.22 Million USD | -68.68% |
| 2009 Q4 | 31.63 Million USD | -16.44% |
| 2008 Q1 | 160.32 Million USD | 0.56% |
| 2008 Q3 | 76.05 Million USD | -43.4% |
| 2008 Q4 | 68.69 Million USD | -9.68% |
| 2008 FY | 160.32 Million USD | 2.18% |
| 2008 Q2 | 134.37 Million USD | -16.19% |
| 2007 Q3 | 158.55 Million USD | 0.53% |
| 2007 FY | 156.89 Million USD | -43.87% |
| 2007 Q1 | 156.89 Million USD | 0.16% |
| 2007 Q4 | 159.43 Million USD | 0.55% |
| 2007 Q2 | 157.72 Million USD | 0.53% |
| 2006 Q3 | 156.1 Million USD | 0.31% |
| 2006 Q1 | 279.51 Million USD | -7.65% |
| 2006 Q2 | 155.62 Million USD | -44.32% |
| 2006 FY | 279.51 Million USD | 1.1% |
| 2006 Q4 | 156.65 Million USD | 0.35% |
| 2005 FY | 276.48 Million USD | 125.55% |
| 2005 Q2 | 277.07 Million USD | 0.21% |
| 2005 Q1 | 276.48 Million USD | 120.04% |
| 2005 Q3 | 277.7 Million USD | 0.23% |
| 2005 Q4 | 302.66 Million USD | 8.99% |
| 2004 Q1 | 122.58 Million USD | 0.14% |
| 2004 Q2 | 122.75 Million USD | 0.14% |
| 2004 Q3 | 122.92 Million USD | 0.14% |
| 2004 Q4 | 125.65 Million USD | 2.22% |
| 2004 FY | 122.58 Million USD | -26.41% |
| 2003 Q2 | 166.8 Million USD | 0.13% |
| 2003 Q4 | 122.41 Million USD | 0.14% |
| 2003 Q3 | 122.23 Million USD | -26.72% |
| 2003 Q1 | 166.58 Million USD | -3.17% |
| 2003 FY | 166.58 Million USD | -19.83% |
| 2002 Q4 | 172.04 Million USD | 2743.64% |
| 2002 Q3 | 6.05 Million USD | -97.07% |
| 2002 Q2 | 206.82 Million USD | -0.47% |
| 2002 Q1 | 207.8 Million USD | -0.47% |
| 2002 FY | 207.8 Million USD | -1.9% |
| 2001 FY | 211.82 Million USD | -4.92% |
| 2001 Q1 | 211.82 Million USD | -3.24% |
| 2001 Q4 | 208.77 Million USD | -0.46% |
| 2001 Q3 | 209.75 Million USD | 1855.71% |
| 2001 Q2 | 10.72 Million USD | -94.94% |
| 2000 Q4 | 218.9 Million USD | -0.54% |
| 2000 FY | 222.79 Million USD | 684.02% |
| 2000 Q3 | 220.09 Million USD | -0.61% |
| 2000 Q1 | 222.79 Million USD | 822.85% |
| 2000 Q2 | 221.44 Million USD | -0.61% |
| 1999 FY | 28.41 Million USD | 119.72% |
| 1999 Q2 | 26.99 Million USD | -5.01% |
| 1999 Q3 | 25.56 Million USD | -5.28% |
| 1999 Q1 | 28.41 Million USD | -10.84% |
| 1999 Q4 | 24.14 Million USD | -5.57% |
| 1998 FY | 12.93 Million USD | 18.5% |
| 1998 Q1 | 12.93 Million USD | 22.49% |
| 1998 Q3 | 24.96 Million USD | 106.2% |
| 1998 Q4 | 31.87 Million USD | 27.66% |
| 1998 Q2 | 12.1 Million USD | -6.38% |
| 1997 Q4 | 10.55 Million USD | -7.25% |
| 1997 FY | 10.91 Million USD | 10.24% |
| 1997 Q1 | 10.91 Million USD | -6.0% |
| 1997 Q2 | 12.21 Million USD | 11.87% |
| 1997 Q3 | 11.38 Million USD | -6.77% |
| 1996 FY | 9.9 Million USD | 17.86% |
| 1996 Q2 | 9.14 Million USD | -7.61% |
| 1996 Q3 | 12.41 Million USD | 35.74% |
| 1996 Q1 | 9.9 Million USD | -13.91% |
| 1996 Q4 | 11.61 Million USD | -6.48% |
| 1995 Q1 | 8.4 Million USD | 52.73% |
| 1995 FY | 8.4 Million USD | 27.27% |
| 1995 Q3 | 7.1 Million USD | -7.79% |
| 1995 Q4 | 11.5 Million USD | 61.97% |
| 1995 Q2 | 7.7 Million USD | -8.33% |
| 1994 Q1 | 6.6 Million USD | 1.54% |
| 1994 Q2 | 6 Million USD | -9.09% |
| 1994 Q3 | 5.4 Million USD | -10.0% |
| 1994 Q4 | 5.5 Million USD | 1.85% |
| 1994 FY | 6.6 Million USD | 214.29% |
| 1993 Q2 | 2 Million USD | -4.76% |
| 1993 Q4 | 6.5 Million USD | 261.11% |
| 1993 Q1 | 2.1 Million USD | 5.0% |
| 1993 Q3 | 1.8 Million USD | -10.0% |
| 1993 FY | 2.1 Million USD | 950.0% |
| 1992 Q3 | - USD | -100.0% |
| 1992 FY | 200 Thousand USD | 0.0% |
| 1992 Q2 | 200 Thousand USD | 0.0% |
| 1992 Q1 | 200 Thousand USD | 0.0% |
| 1992 Q4 | 2 Million USD | 0.0% |
| 1991 Q3 | 300 Thousand USD | 0.0% |
| 1991 Q2 | 300 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -303.99% |
| Agenus Inc. | 137.32 Million USD | -109.526% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 87.72% |
| Aptorum Group Limited | 3.05 Million USD | -9307.553% |
| Ardelyx, Inc. | 51.54 Million USD | -458.19% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -175.055% |
| Bicycle Therapeutics plc | 40.08 Million USD | -617.889% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -186.02% |
| ChromaDex Corporation | 2.57 Million USD | -11073.981% |
| Chimerix, Inc. | 125 Thousand USD | -230084.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -8784.309% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -1010.584% |
| CRISPR Therapeutics AG | 223 Million USD | -29.023% |
| Precision BioSciences, Inc. | 7.72 Million USD | -3625.625% |
| Dyadic International, Inc. | 88.87 Thousand USD | -323665.05% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -1307763.636% |
| Fortress Biotech, Inc. | 60.85 Million USD | -372.805% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -467784.09% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -7469.85% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -319160.13% |
| Incyte Corporation | 29.16 Million USD | -886.661% |
| IO Biotech, Inc. | 1.83 Million USD | -15546.003% |
| Jaguar Health, Inc. | 30.99 Million USD | -828.371% |
| Novavax, Inc. | 168.01 Million USD | -71.252% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -1149.642% |
| Opthea Limited | 200.53 Million USD | -43.481% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -4899.652% |
| ContextLogic Inc. | 6 Million USD | -4695.5% |
| MiMedx Group, Inc. | 48.09 Million USD | -498.204% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -1331.564% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -751329.84% |
| NextCure, Inc. | 5.94 Million USD | -4736.611% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -198334.483% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -1201.298% |
| PDS Biotechnology Corporation | 19.5 Million USD | -1375.071% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -149.16% |
| Pharming Group N.V. | 166.1 Million USD | -73.222% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -4531.096% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -758.511% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -23758.209% |
| Acelyrin, Inc. | 1.19 Million USD | -23997.99% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -62450.0% |
| Summit Therapeutics Inc. | 103.29 Million USD | -178.565% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -7534.12% |
| Senti Biosciences, Inc. | 33.53 Million USD | -757.922% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -5928.284% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -732.648% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -376.998% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -18226.752% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -1032.617% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -175.767% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -39207.377% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -2471.084% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -108.042% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -2041.008% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -1818.2% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -50.698% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -446.413% |
| Fortress Biotech, Inc. | 60.85 Million USD | -372.805% |
| Precigen, Inc. | 5.89 Million USD | -4780.916% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -585.267% |
| AlloVir, Inc. | 16.64 Million USD | -1628.316% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -337.566% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -195.532% |
| ImmuCell Corporation | 10.54 Million USD | -2629.758% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -25476.0% |
| Onconetix, Inc. | 118.85 Thousand USD | -241980.82% |
| PureTech Health plc | 18.25 Million USD | -1476.603% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -290536.364% |
| Elevation Oncology, Inc. | 30.13 Million USD | -854.74% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -1008.188% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -571.106% |
| Innoviva, Inc. | 446.23 Million USD | 35.52% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -34441.417% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -430350.003% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -39.021% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -304.138% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -8925.408% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -27619.653% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -1188.766% |
| Aptose Biosciences Inc. | 621 Thousand USD | -46233.333% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -28361.799% |
| Century Therapeutics, Inc. | 46.65 Million USD | -516.679% |
| Kura Oncology, Inc. | 9.33 Million USD | -2983.262% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -977.64% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -208400.0% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -2965.85% |
| Autolus Therapeutics plc | 47.91 Million USD | -500.513% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -5764.859% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -4148.191% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -120.213% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -3450.031% |
| IGM Biosciences, Inc. | 34.67 Million USD | -729.863% |
| INmune Bio, Inc. | 397 Thousand USD | -72376.071% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -65.597% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -6996.979% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -195702.625% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -478.096% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -427.268% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -529.703% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 39.217% |
| Verastem, Inc. | 40.08 Million USD | -617.782% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -6436.347% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -2761.846% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -4285.46% |
| Histogen Inc. | 4.38 Million USD | -6463.184% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -32522.449% |
| Organovo Holdings, Inc. | 888 Thousand USD | -32302.027% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -859.1% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -6760.515% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -1422.784% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -280.092% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -308941.502% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -1010.626% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -107664.045% |
| Amarin Corporation plc | 8.73 Million USD | -3193.236% |
| Mesoblast Limited | 100.48 Million USD | -186.347% |
| Turnstone Biologics Corp. | 1.18 Million USD | -24099.327% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -267.335% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -263872.477% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -250.852% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -51.481% |
| Better Therapeutics, Inc. | 10.34 Million USD | -2680.537% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -1144.238% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -209.277% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -22170.124% |
| Gritstone bio, Inc. | 40.14 Million USD | -616.745% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -15761.632% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -87.333% |
| Insmed Incorporated | 1.19 Billion USD | 75.889% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -4431.181% |
| OmniAb, Inc. | 22.07 Million USD | -1203.42% |
| Alector, Inc. | 30.45 Million USD | -844.74% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -183.355% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -3475.618% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 32.552% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1605.572% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -405.73% |
| Immunic, Inc. | 639 Thousand USD | -44928.169% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -864.922% |
| Veracyte, Inc. | 7.52 Million USD | -3723.654% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 55.381% |
| FibroGen, Inc. | 89.69 Million USD | -220.78% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -6534.309% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -219771.163% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 94.367% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -777548.649% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -14431.818% |
| TG Therapeutics, Inc. | 100.11 Million USD | -187.391% |
| Galecto, Inc. | 66 Thousand USD | -435854.545% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -211466.176% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 82.374% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -4683.541% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -5231.295% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -15761.632% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -1241.586% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -687.115% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -55553.772% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -536.064% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -841.094% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -542.226% |
| Vaxxinity, Inc. | 13.26 Million USD | -2069.582% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 64.533% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -63974.842% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -3173.751% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 89.355% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -90953.797% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -6354.24% |
| Ainos, Inc. | 5.92 Million USD | -4759.027% |
| Pluri Inc. | 29.05 Million USD | -890.362% |
| Prothena Corporation plc | 10.72 Million USD | -2583.798% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -1349.448% |
| Celularity Inc. | 26.17 Million USD | -999.171% |
| Rallybio Corporation | 173 Thousand USD | -166217.919% |
| Cue Biopharma, Inc. | 4.2 Million USD | -6747.454% |
| MeiraGTx Holdings plc | 72.11 Million USD | -298.966% |
| Omeros Corporation | 329.7 Million USD | 12.731% |
| Humacyte, Inc. | 38.6 Million USD | -645.415% |
| Immunocore Holdings plc | 82.64 Million USD | -248.156% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -17738.19% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -7943.892% |
| Blueprint Medicines Corporation | 610.96 Million USD | 52.905% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -19634.568% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -202.272% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -491.016% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -216.531% |
| Pulmatrix, Inc. | 8.32 Million USD | -3355.386% |
| Elicio Therapeutics, Inc. | 6 Million USD | -4689.912% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -2122.711% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -197.405% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -61249.68% |
| Cytokinetics, Incorporated | 607.37 Million USD | 52.627% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -3210.285% |
| Nutriband Inc. | 79.82 Thousand USD | -360346.471% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -6316.815% |
| Vor Biopharma Inc. | 31.83 Million USD | -803.959% |
| Roivant Sciences Ltd. | 477.85 Million USD | 39.787% |
| Evogene Ltd. | 10.65 Million USD | -2600.929% |
| ProKidney Corp. | 3.61 Million USD | -7870.36% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -37809.091% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -1092849.935% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 83.423% |
| CorMedix Inc. | 517.01 Thousand USD | -55552.372% |
| BioLineRx Ltd. | 6.62 Million USD | -4241.129% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -681.068% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -301.068% |
| Atai Life Sciences N.V. | 15.21 Million USD | -1791.592% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -34056.429% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -112735.294% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -566.813% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -69965.261% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -20917.531% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -43291.711% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -61.583% |
| Biomea Fusion, Inc. | 7.83 Million USD | -3574.713% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -1.237% |
| Mereo BioPharma Group plc | 5.3 Million USD | -5328.868% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -13282.791% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -48833.673% |
| Absci Corporation | 4.66 Million USD | -6074.464% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -2397.223% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -1167.812% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -2775.862% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -2400.913% |
| Allakos Inc. | 38.21 Million USD | -652.924% |
| Imunon, Inc. | 1.13 Million USD | -25155.136% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -3234.454% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -34317.464% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -2877200.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -225.685% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -6010.214% |
| XOMA Corporation | 118.51 Million USD | -142.773% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -2757.583% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -675.992% |
| aTyr Pharma, Inc. | 13.76 Million USD | -1989.998% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -3542.613% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -1052.58% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -1324.053% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -1918100.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -103329.311% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1890.542% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 80.808% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -211197.394% |
| UroGen Pharma Ltd. | 98.55 Million USD | -191.961% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -92.96% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -1409.047% |
| Entera Bio Ltd. | 256 Thousand USD | -112294.531% |
| GH Research PLC | 631 Thousand USD | -45499.049% |
| Lisata Therapeutics, Inc. | 137.00 USD | -210021797.81% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -44717.757% |
| Xencor, Inc. | 14.64 Million USD | -1865.1% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -191399.557% |
| Replimune Group, Inc. | 71.99 Million USD | -299.681% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -191720.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -4006.908% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -211197.394% |
| Portage Biotech Inc. | 7000.00 USD | -4110328.571% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -43291.711% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -20035.059% |
| OncoCyte Corporation | 2.2 Million USD | -12954.9% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -429957.544% |
| Purple Biotech Ltd. | 163 Thousand USD | -176421.472% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -11250.296% |
| scPharmaceuticals Inc. | 38.81 Million USD | -641.362% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -1039.796% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -394050.685% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -15427.793% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -992.037% |
| Curis, Inc. | 1.48 Million USD | -19223.707% |
| Daré Bioscience, Inc. | 3.91 Million USD | -7251.912% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -41138.901% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -4795400.0% |
| BeiGene, Ltd. | 197.61 Million USD | -45.599% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -31466.648% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -257.096% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -454.511% |
| bluebird bio, Inc. | 224.41 Million USD | -28.211% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 51.487% |
| DBV Technologies S.A. | 4.52 Million USD | -6257.269% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -21372.388% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -2853.5% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -7538.174% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 23.732% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -571.059% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -16657.717% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -30905.388% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -1547.278% |
| MacroGenics, Inc. | 30.19 Million USD | -852.875% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -1525.318% |
| Prime Medicine, Inc. | 4.35 Million USD | -6503.856% |
| Aditxt, Inc. | 1.04 Million USD | -27520.029% |
| Adagene Inc. | 13.54 Million USD | -2025.032% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1994.562% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 44.529% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1583.321% |
| SciSparc Ltd. | 24 Thousand USD | -1198775.0% |
| Vericel Corporation | 81.85 Million USD | -251.508% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -250.818% |
| Generation Bio Co. | 89.77 Million USD | -220.505% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -1196.957% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -42.582% |
| Invivyd, Inc. | 722 Thousand USD | -39751.801% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -493.233% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -9841096.006% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -7422.353% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -1250900.0% |
| 2seventy bio, Inc. | 244.01 Million USD | -17.916% |
| ADMA Biologics, Inc. | 130.59 Million USD | -120.324% |
| Clene Inc. | 7.15 Million USD | -3923.07% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -8422.154% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -16.2% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -26033.515% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -109359.228% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -49.377% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -913.027% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -2885.061% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -157.654% |
| Evaxion Biotech A/S | 8.48 Million USD | -3289.545% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -284.024% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -344.611% |
| Trevena, Inc. | 35.23 Million USD | -716.649% |
| Surrozen, Inc. | 882 Thousand USD | -32522.449% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -4528.861% |
| Cingulate Inc. | 135.09 Thousand USD | -212877.15% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -1122.354% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -501.946% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -159750.0% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -1033.733% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -1550.112% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -30640.385% |
| Statera Biopharma, Inc. | 11.43 Million USD | -2417.072% |
| ImmunityBio, Inc. | 836.95 Million USD | 65.622% |
| Korro Bio, Inc. | 31.21 Million USD | -821.739% |
| Kineta, Inc. | 150 Thousand USD | -191720.0% |
| BioVie Inc. | 349.89 Thousand USD | -82133.476% |
| Codexis, Inc. | 12.24 Million USD | -2250.159% |
| Celularity Inc. | 26.17 Million USD | -999.171% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -505.047% |
| Celcuity Inc. | 37.03 Million USD | -676.905% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -163063.118% |
| Cibus, Inc. | 17.67 Million USD | -1527.985% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -8415.241% |
| Kodiak Sciences Inc. | 100 Million USD | -187.73% |
| Annexon, Inc. | 29.19 Million USD | -885.714% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -345.216% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -25544.385% |
| Avalo Therapeutics, Inc. | 2 Million USD | -14286.5% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 79.453% |
| Eyenovia, Inc. | 8.95 Million USD | -3112.265% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -338.219% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -3433.898% |
| Arcellx, Inc. | 50.84 Million USD | -465.941% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -19634.568% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -1254.789% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -27172.986% |
| Moolec Science SA | 99.04 Thousand USD | -290401.383% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -941.707% |
| Geron Corporation | 35.05 Million USD | -720.89% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -48585.279% |
| Royalty Pharma plc | 6.13 Billion USD | 95.31% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -17423.143% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -906364.621% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -1143.002% |
| Humacyte, Inc. | 38.6 Million USD | -645.415% |
| Structure Therapeutics Inc. | 4.01 Million USD | -7069.948% |
| 89bio, Inc. | 24.79 Million USD | -1060.436% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -2214.058% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -15319.614% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -27780.814% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -189.153% |
| Notable Labs, Ltd. | 1.52 Million USD | -18755.177% |
| Liquidia Corporation | 2.36 Million USD | -12071.32% |
| Mustang Bio, Inc. | 1.97 Million USD | -14446.512% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1994.562% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -4038.214% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -90666.562% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -476.879% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -2895.939% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -439256.228% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -211466.176% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -4493.391% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -221230.769% |
| PepGen Inc. | 17.1 Million USD | -1582.632% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -60602.532% |
| United Therapeutics Corporation | 300 Million USD | 4.09% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -1101.829% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -6811.848% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -49680.277% |
| XOMA Corporation | 118.51 Million USD | -142.773% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -777548.649% |
| Bionomics Limited | 117.62 Million USD | -144.61% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -30739.228% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5028.877% |
| uniQure N.V. | 130.06 Million USD | -121.22% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -391.091% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -41843.149% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -6534.309% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -20674.729% |
| Altimmune, Inc. | 175 Thousand USD | -164317.143% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 25.816% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5028.877% |
| Compugen Ltd. | 719 Thousand USD | -39918.081% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -5579.629% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -240.287% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -2797.583% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -4410.582% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -214.769% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -2797.583% |
| Instil Bio, Inc. | 81.42 Million USD | -253.359% |
| argenx SE | 15.35 Million USD | -1773.974% |
| Immunome, Inc. | 1.34 Million USD | -21372.388% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -53580.97% |
| Verona Pharma plc | 48.37 Million USD | -494.803% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -3022.07% |
| Shattuck Labs, Inc. | 3.4 Million USD | -8347.739% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -338405.882% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -171167.857% |
| Moolec Science SA | 99.04 Thousand USD | -290401.383% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -2508.124% |
| AnaptysBio, Inc. | 16.03 Million USD | -1694.163% |
| Design Therapeutics, Inc. | 2.33 Million USD | -12227.763% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -1062771.708% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -4695.5% |
| Achilles Therapeutics plc | 1.07 Million USD | -26640.706% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -3022.07% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -1443168.459% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1618.568% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -360346.471% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -3856353.559% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -2213207.692% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 15.987% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -1075.176% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -11409.246% |
| Palisade Bio, Inc. | 90 Thousand USD | -319600.0% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -148214.433% |
| Beam Therapeutics Inc. | 159.91 Million USD | -79.931% |
| Neurogene Inc. | 13.37 Million USD | -2051.574% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 6.1% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -995.572% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -480876.898% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -28673.0% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -610.304% |
| Athira Pharma, Inc. | 1.21 Million USD | -23542.564% |
| Vaccinex, Inc. | 26 Thousand USD | -1106553.846% |
| HCW Biologics Inc. | 6.3 Million USD | -4464.015% |
| XOMA Corporation | 118.51 Million USD | -142.773% |
| Nektar Therapeutics | 112.62 Million USD | -155.476% |
| Arvinas, Inc. | 800 Thousand USD | -35866.25% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1890.542% |
| Merus N.V. | 10.48 Million USD | -2643.421% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -1833.02% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -2042.602% |
| Rezolute, Inc. | 1.66 Million USD | -17233.133% |
| Clene Inc. | 7.15 Million USD | -3923.07% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -392180.635% |
| BeyondSpring Inc. | 3.36 Million USD | -8453.21% |
| Synlogic, Inc. | 12.49 Million USD | -2203.499% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -781.094% |
| Krystal Biotech, Inc. | 6.62 Million USD | -4246.375% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -68.343% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -4698.699% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -607296.931% |
| MannKind Corporation | 252.15 Million USD | -14.11% |
| Ikena Oncology, Inc. | 7.18 Million USD | -3907.382% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -144487.94% |
| Gossamer Bio, Inc. | 197.4 Million USD | -45.756% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -55232.692% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -2.276% |
| Mural Oncology plc | 8.91 Million USD | -3128.931% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -557.879% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -19936.908% |
| Champions Oncology, Inc. | 6.09 Million USD | -4622.304% |
| REGENXBIO Inc. | 82.22 Million USD | -249.943% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -58144.586% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -6389.175% |
| Vaxart, Inc. | 2.62 Million USD | -10869.501% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -105826.79% |
| Cellectis S.A. | 36.24 Million USD | -693.935% |
| Longeveron Inc. | 1.44 Million USD | -19770.856% |
| Repare Therapeutics Inc. | 1.01 Million USD | -28388.119% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 74.594% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -542.699% |
| Revolution Medicines, Inc. | 80.57 Million USD | -257.096% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -8869.14% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -162459.322% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -233826.829% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 60.297% |
| Denali Therapeutics Inc. | 44.98 Million USD | -539.67% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -2201.058% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -212877.15% |
| Passage Bio, Inc. | 22.92 Million USD | -1155.312% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -4664.531% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -44371.406% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -1326.878% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -58620.408% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -70516.04% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -24119.697% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -61644.635% |
| OmniAb, Inc. | 22.07 Million USD | -1203.42% |
| Anew Medical, Inc. | 1.54 Million USD | -18583.766% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -873.377% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -3085.32% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -825.474% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -6996.979% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -458.081% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -4419.083% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1936.45% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -42716.964% |
| Alumis Inc. Common Stock | 30.86 Million USD | -832.372% |
| Equillium, Inc. | 384 Thousand USD | -74829.688% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -4571.7% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -90.488% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -488.658% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -239073.081% |
| Dominari Holdings Inc. | 3.02 Million USD | -9402.312% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -1455066.136% |
| vTv Therapeutics Inc. | 169 Thousand USD | -170154.438% |
| Bio-Techne Corporation | 319 Million USD | 9.803% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -404.896% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -61.134% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -1767.528% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -2223.589% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -5885.646% |
| Nkarta, Inc. | 82.27 Million USD | -249.739% |
| BioCardia, Inc. | 982 Thousand USD | -29200.407% |
| Iterum Therapeutics plc | 18.95 Million USD | -1417.884% |